US Broker Ratings

Globus Medical, Inc. (GMED) Stock Analysis: A Strong Buy with 25% Upside Potential

Globus Medical, Inc. (NYSE: GMED), a key player in the medical devices sector, is catching the eye of investors with its promising growth prospects and robust financial health. With a..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring a Potential 102.59% Upside in the Booming RNA Therapeutics Market

Atrium Therapeutics, Inc. (NASDAQ: RNA), a burgeoning player in the biotechnology sector, is capturing investor attention with its innovative approach to RNA therapeutics targeting cardiomyopathies. With a market capitalization of..

Guardant Health, Inc. (GH) Stock Analysis: Assessing Growth Potential with a 15.32% Upside

Guardant Health, Inc. (GH), a leader in precision oncology, is garnering attention from investors with a robust growth trajectory and an enticing potential upside of 15.32% based on current analyst..

BrightSpring Health Services (BTSG): Analyst Ratings Suggest a 26% Upside Potential for this Healthcare Powerhouse

BrightSpring Health Services, Inc. (BTSG), a prominent player in the healthcare sector, is attracting significant investor attention, thanks to its robust growth trajectory and bullish analyst ratings. Headquartered in Louisville,..

Cytokinetics, Incorporated (CYTK) Stock Analysis: 41.81% Potential Upside and Strong Buy Ratings

Investors seeking opportunities in the biotechnology sector might find Cytokinetics, Incorporated (NASDAQ: CYTK) an intriguing prospect. This South San Francisco-based biopharmaceutical company is dedicated to pioneering innovative treatments for muscle-related..

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Innovations with a 15.99% Upside Potential

TransMedics Group, Inc. (TMDX) is at the forefront of revolutionizing the organ transplant industry, with a focus on enhancing the viability and success rates of organ transplants. As a leading..

Baxter International Inc. (BAX) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential and Price Dynamics

Investors eyeing the healthcare sector should pay close attention to Baxter International Inc. (NYSE: BAX), a well-established player in the medical instruments and supplies industry. With a market capitalization of..

Vaxcyte, Inc. (PCVX) Stock Analysis: Potential 87.70% Upside with Innovative Vaccine Pipeline

Vaxcyte, Inc. (PCVX), a prominent player in the biotechnology sector, is gaining significant attention from investors, driven by its robust vaccine innovation pipeline and promising market potential. Based in San..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech with Strong Revenue Growth and Substantial Upside Potential

In the dynamic world of biotechnology, TG Therapeutics, Inc. (NASDAQ: TGTX) stands out with its robust pipeline and impressive growth metrics. With a market capitalization of $7.62 billion, this commercial-stage..

Waters Corporation (WAT) Stock Analysis: A Strong Buy with a 7% Upside Potential

Waters Corporation (NYSE: WAT), a leader in the diagnostics and research industry within the healthcare sector, presents a compelling investment opportunity for individual investors. With its current market cap of..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Strong Potential Upside with Robust Analyst Ratings

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a formidable player in the healthcare sector, specializes in medical devices and boasts a significant market cap of $18.42 billion. As an investor, understanding..

Sarepta Therapeutics, Inc. (SRPT) Investor Outlook: Analyzing the 31.63% Potential Upside

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, is capturing the attention of investors with its significant 31.63% potential upside. This commercial-stage biopharmaceutical firm is dedicated to..

Option Care Health, Inc. (OPCH) Investor Outlook: Analyzing a 20% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector, particularly within the medical care facilities industry. With a market cap of $3.56 billion, this U.S.-based company is..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Analyzing a 22.4% Potential Upside for This Biotech Innovator

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a key player in the biotechnology sector focusing on rare neuroendocrine diseases, has caught the eye of investors with its innovative pipeline and promising market..

Oscar Health, Inc. (OSCR) Stock Analysis: Impressive Revenue Growth and What It Means for Investors

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, continues to catch the eye of investors with its impressive 70.40% revenue growth. As a company that..

argenx SE (ARGX) Stock Analysis: Unlocking a 25% Upside in the Biotech Sector

argenx SE (NASDAQ: ARGX), a prominent player in the biotechnology industry, is making waves with its innovative therapies targeting autoimmune diseases. With a market capitalization of $54.12 billion, the Amsterdam-based..

Bio-Rad Laboratories (BIO) Stock Analysis: Exploring a Potentially Overvalued Healthcare Giant

Bio-Rad Laboratories, Inc. (NYSE: BIO), a formidable player in the medical devices industry, has captured the attention of investors with its stock price soaring to $352.47, marking the zenith of..

Zoetis Inc. (ZTS) Investor Outlook: Analyzing a Potential 43% Upside in the Healthcare Sector

Zoetis Inc. (NYSE: ZTS) remains a prominent player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic products. With a market capitalization of $30.02..

Lantheus Holdings (LNTH): Investor Outlook on Strong Upside Potential and Robust Product Portfolio

Lantheus Holdings, Inc. (NASDAQ: LNTH) has emerged as a formidable player in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a market capitalization of..

Glaukos Corporation (GKOS) Stock Analysis: Target Price Insights and Growth Prospects

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, has recently captured significant attention from investors due to its robust revenue growth..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds